Skip to main content
Log in

Postpartum Weight Retention is Associated with Elevated Ratio of Oxidized LDL Lipids to HDL-Cholesterol

  • Original Article
  • Published:
Lipids

Abstract

Oxidized LDL lipids (ox-LDL) are associated with lifestyle diseases such as cardiovascular diseases, metabolic syndrome and type 2 diabetes. The present study investigated how postpartum weight retention effects on ox-LDL and serum lipids. The study is a nested comparative research of a cluster-randomized controlled trial, NELLI (lifestyle and counselling during pregnancy). During early pregnancy (8–12 weeks) and 1 year postpartum, 141 women participated in measurements for determining of plasma lipids: total cholesterol (T-C), LDL-cholesterol (LDL-C), HDL-cholesterol (HDL-C), triacylglycerols (TAG) and ox-LDL. Subjects were stratified into tertiles (weight loss, unaltered weight and weight gain groups) based on their weight change from baseline to follow-up. Ox-LDL was determined by baseline level of conjugated dienes in LDL lipids. Among the group of weight gainers, concentration of TAG reduced less (−0.14 vs. −0.33, p = 0.002), HDL-C reduced more (−0.31 vs. −0.16, p = 0.003) and ox-LDL/HDL-C ratio increased (3.0 vs. −0.2, p = 0.003) when compared to group of weight loss. Both T-C and LDL-C elevated more (0.14 vs. −0.21, p = 0.008; 0.31 vs. 0.07, p = 0.015) and TAG and ox-LDL reduced less (−0.33 vs. 0.20, p = 0.033; −3.33 vs. −0.68, p = 0.026) in unaltered weight group compared to weight loss group. The women who gained weight developed higher TAG and ox-LDL/HDL-C ratio as compared to those who lost weight. Postpartum weight retention of 3.4 kg or more is associated with atherogenic lipid profile.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

Abbreviations

BMI:

Body mass index

GDM:

Gestational diabetes

HDL-C:

HDL cholesterol

LDL-C:

LDL cholesterol

NELLI:

Name of the study, lifestyle and counselling during pregnancy

OGTT:

Oral glucose tolerance test

ox-LDL:

Oxidized LDL

T-C:

Total cholesterol

TAG:

Triacylglycerols

References

  1. Toikka JO, Ahotupa M, Viikari JSA, Niinikoski H, Taskinen MR, Irjala K, Hartiala JJ, Raitakari OT (1999) Constantly low HDL-cholesterol concentration relates to endothelial dysfunction and increased in vivo LDL-oxidation in healthy young men. Atherosclerosis 147:133–138

    Article  PubMed  CAS  Google Scholar 

  2. Tsimikas S, Miller YI (2011) Oxidative modification of lipoproteins: mechanisms, role in inflammation and potential clinical applications in cardiovascular disease. Curr Pharm Des 17:27–37

    Article  PubMed  CAS  Google Scholar 

  3. Chisolm GM 3rd, Hazen SL, Fox PL, Cathcart MK (1999) The oxidation of lipoproteins by monocytes-macrophages. Biochemical and biological mechanisms. J Biol Chem 274(37):25959–25962

    Article  PubMed  CAS  Google Scholar 

  4. Ahotupa M, Vasankari TJ (1999) Baseline diene conjugation in LDL lipids: an indicator of circulating oxidized LDL. Free Radic Biol Med 27:1141–1150

    Article  PubMed  CAS  Google Scholar 

  5. Wang JS, Chen YW, Chow SE, Ou HC, Sheu HH (2005) Exercise paradoxically modulates oxidized low density lipoprotein-induced adhesion molecules expression and trans-endothelial migration of monocyte in men. Thromb Heamost 94:846–852

    Google Scholar 

  6. Meisinger C, Baumert J, Khuseyinova N, Loewel H, Koenig W (2005) Plasma oxidized low-density lipoprotein, a strong predictor for acute coronary heart disease events in apparently healthy, middle-aged men from the general population. Circulation 112(5):651–657

    Article  PubMed  CAS  Google Scholar 

  7. Juul K, Nielsen LB, Munkholm K, Stender S, Nordestgaard BG (1996) Oxidation of plasma low-density lipoprotein accelerates its accumulation and degradation in the arterial wall in vivo. Circulation 94:1698–1704

    Article  PubMed  CAS  Google Scholar 

  8. Kontush A, Chapman MJ (2010) Antiatherogenic function of HDL particle subpopulations: focus on antioxidative activities. Curr Opin Lipidol 21(4):312–318

    Article  PubMed  CAS  Google Scholar 

  9. Rye KA, Bursill CA, Lambert G, Tabet F, Barter PJ (2009) The metabolism and anti-atherogenic properties of HDL. J Lipid Res 50(Suppl):S195–S200

    PubMed  Google Scholar 

  10. Bandeali S, Farmer J (2012) High-density lipoprotein and atherosclerosis: the role of antioxidant activity. Curr Atheroscler Rep 14(2):101–107

    Article  PubMed  CAS  Google Scholar 

  11. Johnston N, Jernberg T, Lagerqvist B, Siegbahn A, Wallentin L (2006) Improved identification of patients with coronary artery disease by the use of new lipid and lipoprotein biomarkers. Am J Cardiol 97(5):640–645

    Article  PubMed  CAS  Google Scholar 

  12. Linna M, Ahotupa M, Löppönen MK, Irjala K, Vasankari T (2013) Circulating oxidised LDL lipids, when proportioned to HDL-c, emerged as a risk factor of all-cause mortality in a population-based survival study. Age Ageing 42(1):110–113

    Article  PubMed  Google Scholar 

  13. Haslam DW, James WP (2005) Obesity. Lancet 366(9492):1197–1209 Review

    Article  PubMed  Google Scholar 

  14. Njajou OT, Kanaya AM, Holvoet P, Connelly S, Strotmeyer ES, Harris TB, Cummings SR, Hsueh WC, Health ABC Study (2009) Association between oxidized LDL, obesity and type 2 diabetes in a population-based cohort, the Health, Aging and Body Composition Study. Diabetes Metab Res Rev 25(8):733–739

    Article  PubMed  CAS  Google Scholar 

  15. Holvoet P, Lee DH, Steffes M, Gross M, Jacobs DR Jr (2008) Association between circulating oxidized low-density lipoprotein and incidence of the metabolic syndrome. JAMA 299(19):2287–2293

    Article  PubMed  CAS  Google Scholar 

  16. Vasankari T, Fogelholm M, Kukkonen-Harjula K, Nenonen A, Kujala U, Oja P, Vuori I, Pasanen P, Neuvonen K, Ahotupa M (2001) Reduced oxidized low-density lipoprotein after weight reduction in obese premenopausal women. Int J Obes Relat Metab Disord 25(2):205–211

    Article  PubMed  CAS  Google Scholar 

  17. Linna MS, Borg P, Kukkonen-Harjula K, Fogelholm M, Nenonen A, Ahotupa M, Vasankari TJ (2007) Successful weight maintenance preserves lower levels of oxidized LDL achieved by weight reduction in obese men. Int J Obes (Lond) 31(2):245–253

    Article  CAS  Google Scholar 

  18. Poobalan A, Aucott L, Smith WC, Avenell A, Jung R, Broom J, Grant AM (2004) Effects of weight loss in overweight/obese individuals and long-term lipid outcomes—a systematic review. Obes Rev 5(1):43–50

    Article  PubMed  CAS  Google Scholar 

  19. Reinehr T, Andler W (2004) Changes in the atherogenic risk factor profile according to degree of weight loss. Arch Dis Child 89(5):419–422

    Article  PubMed  CAS  Google Scholar 

  20. Wolfe WS, Sobal J, Olson CM, Frongillo EA Jr (1997) Parity-associated body weight: modification by sociodemographic and behavioural factors. Obes Res 5:131–141

    Article  PubMed  CAS  Google Scholar 

  21. Gore SA, Brown DM, West DS (2003) The role of postpartum weight retention in obesity among women: a review of the evidence. Ann Behav Med 26(2):149–159 Review

    Article  PubMed  Google Scholar 

  22. Brown WJ, Hockey R, Dobson AJ (2010) Effects of having a baby on weight gain. Am J Prev Med 38:163–170

    Article  PubMed  Google Scholar 

  23. Luoto R, Männistö S, Raitanen J (2011) Ten-year trends in obesity by parity-results from a national FINRISK population study. Gend Med 8(6):399–406

    Article  PubMed  Google Scholar 

  24. Luoto R, Kinnunen TI, Aittasalo M, Kolu P, Raitanen J, Ojala K, Mansikkamäki K, Lamberg S, Vasankari T, Komulainen T, Tulokas S (2011) Primary prevention of gestational diabetes mellitus and large-for-gestational-age newborns by lifestyle counseling: a cluster-randomized controlled trial. PLoS Med. doi:10.1371/journal.pmed.1001036

    PubMed  Google Scholar 

  25. Luoto RM, Kinnunen TI, Aittasalo M, Ojala K, Mansikkamäki K, Toropainen E, Kolu P, Vasankari T (2010) Prevention of gestational diabetes: design of a cluster-randomized controlled trial and one-year follow-up. BMC Pregnancy Childbirth. doi:10.1186/1471-2393-10-39

    PubMed  Google Scholar 

  26. American Diabetes Association (2006) Diagnosis and classification of diabetes mellitus. Diabetes Care 29(Suppl 1):S43–S48

    Google Scholar 

  27. Ahotupa M, Ruutu M, Mäntylä E (1996) Simple methods of quantifying oxidation products and antioxidant potential of low density lipoproteins. Clin Biochem 29:139–144

    Article  PubMed  CAS  Google Scholar 

  28. Ahotupa M, Marniemi J, Lehtimäki T, Talvinen K, Raitakari OT, Vasankari T, Viikari J, Luoma J, Ylä-Herttuala S (1998) Baseline diene conjugation in LDL lipids as a direct measure of in vivo LDL oxidation. Clin Biochem 31:257–261

    Article  PubMed  CAS  Google Scholar 

  29. Huang H, Mai W, Liu D, Hao Y, Tao J, Dong Y (2008) The oxidation ratio of LDL: a predictor for coronary artery disease. Dis Markers 24(6):341–349

    Article  PubMed  CAS  Google Scholar 

  30. Navab M, Reddy ST, Van Lenten BJ, Anantharamaiah GM, Fogelman AM (2009) The role of dysfunctional HDL in atherosclerosis. J Lipid Res 50(Suppl):S145–S149

    PubMed  Google Scholar 

  31. Bartels A, Egan N, Broadhurst DI, Khashan AS, Joyce C, Stapleton M, O’Mullane J, O’Donoghue K (2012) Maternal serum cholesterol levels are elevated from the 1st trimester of pregnancy: a cross-sectional study. J Obstet Gynaecol 32(8):747–752

    Article  PubMed  CAS  Google Scholar 

  32. Fialová L, Mikulíková L, Malbohan I, Benesová O, Stípek S, Zima T, Zwinger A (2002) Antibodies against oxidized low density lipoproteins in pregnant women. Physiol Res 51(4):355–361

    PubMed  Google Scholar 

  33. Toescu V, Nuttall SL, Martin U, Nightingale P, Kendall MJ, Brydon P, Dunne F (2004) Changes in plasma lipids and markers of oxidative stress in normal pregnancy and pregnancies complicated by diabetes. Clin Sci (Lond) 106(1):93–98

    Article  CAS  Google Scholar 

  34. Makedou K, Kourtis A, Gkiomisi A, Toulis KA, Mouzaki M, Anastasilakis AD, Gerou S, Gavana E, Agorastos T (2011) Oxidized low-density lipoprotein and adiponectin levels in pregnancy. Gynecol Endocrinol 27(12):1070–11073

    Article  PubMed  CAS  Google Scholar 

  35. Peltonen M, Harald K, Männistö S, Saarikoski L, Peltomäki P, Lund L, Sundvall J, Juolevi A, Laatikainen T, Aldén-Nieminen H, Luoto R, Jousilahti P, Salomaa V, Taimi M, Vartiainen E (2008) The National FINRISK 2007 Study. Statistics, Publications of the National Public Health Institute B35/2008 (in Finnish), Helsinki, Finland

  36. Schneider S, Bock C, Wetzel M, Maul H, Loerbroks A (2012) The prevalence of gestational diabetes in advanced economies. J Perinat Med 40(5):511–520

    Article  PubMed  Google Scholar 

  37. Puhkala J, Kinnunen TI, Vasankari T, Kukkonen-Harjula K, Raitanen J, Luoto R (2013) Prevalence of metabolic syndrome one year after delivery in Finnish women at increased risk for gestational diabetes mellitus during pregnancy. J Pregnancy. doi:10.1155/2013/139049

    PubMed  Google Scholar 

  38. Valle-Gottlieb MG, da Cruz IB, Duarte MM, Moresco RN, Wiehe M, Schwanke CH, Bodanese LC (2010) Associations among metabolic syndrome, ischemia, inflammatory, oxidatives, and lipids biomarkers. J Clin Endocrinol Metab 95(2):586–591

    Article  PubMed  Google Scholar 

  39. Vasankari T, Ahotupa M, Viikari J, Nuotio I, Tikkanen M (2005) Effects of statin therapy on LDL oxidation. Atherosclerosis 179:207–209

    Article  PubMed  CAS  Google Scholar 

  40. Kostapanos MS, Milionis HJ, Elisaf MS (2008) An overview of the extra-lipid effects of rosuvastatin. J Cardiovasc Pharmacol Ther 13(3):157–174

    Article  PubMed  CAS  Google Scholar 

  41. Resch U, Tatzber F, Budinsky A, Sinzinger H (2006) Reduction of oxidative stress and modulation of autoantibodies against modified low-density lipoprotein after rosuvastatin therapy. Br J Clin Pharmacol 61(3):262–274

    Article  PubMed  CAS  Google Scholar 

  42. Dong Y, Steffen BT, Cao J, Tsai AK, Ordovas J, Straka R, Zhou X, Kabagambe E, Hanson NQ, Arnett D, Tsai MY (2011) Effects of fenofibrate on plasma oxidized LDL and 8-isoprostane in a sub-cohort of GOLDN participants. Atherosclerosis 214(2):422–425

    Article  PubMed  CAS  Google Scholar 

  43. Ahotupa M, Rauramo I, Vasankari T, Skouby SO, Hakonen T (2004) Estrogen replacement therapy in combination with continuous intrauterine progestin administration reduces the amount of circulating oxidized LDL in premenopausal women: dependence on the dose of progestin. Ann Med 36(4):278–284

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This study was funded by Competitive Research Funding of the Tampere University Hospital, Juho Vainio Foundation, Academy of Finland, Ministry of Education and Culture, and Ministry of Social Affairs and Health. We are thankful to Tiina Solakivi, PhD, associate professor at the Medical School at the University of Tampere, who was responsible for the laboratory testing.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jatta Puhkala.

About this article

Cite this article

Puhkala, J., Luoto, R., Ahotupa, M. et al. Postpartum Weight Retention is Associated with Elevated Ratio of Oxidized LDL Lipids to HDL-Cholesterol. Lipids 48, 1227–1235 (2013). https://doi.org/10.1007/s11745-013-3852-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11745-013-3852-9

Keywords

Navigation